Dev4 LLC

SEC filing

Biotechnology · Houston, TX

Form D on EDGAR

Amount raised$1.5Msold at filing

Total offering$2M$453K still open

Investors in the raise27count reported to the SEC

FiledSep 5, 2025first sale Aug 26, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Arnold-Peter WeissExecutive Officer, Director

Lance TerrillExecutive Officer

Stephanie PadillaExecutive Officer

Jeff SeaveyExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.